These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18706002)

  • 1. Polypill: for Pollyanna.
    Spence JD
    Int J Stroke; 2008 May; 3(2):92-7. PubMed ID: 18706002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits, challenges, and registerability of the polypill.
    Sleight P; Pouleur H; Zannad F
    Eur Heart J; 2006 Jul; 27(14):1651-6. PubMed ID: 16603580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do the current medical and economic times dictate the need for the "polypill"?
    Rifai L; Khan BV
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):775-6. PubMed ID: 20021541
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
    Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N
    Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996
    [No Abstract]   [Full Text] [Related]  

  • 5. A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years.
    Robinson JG; Maheshwari N
    Am J Cardiol; 2005 Feb; 95(3):373-8. PubMed ID: 15670547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in patients with type 2 diabetes.
    Shanks M; Holmes DT; Cermakova L; Frohlich J
    CMAJ; 2005 Apr; 172(9):1160-1. PubMed ID: 15851694
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
    Sepanlou SG; Farzadfar F; Jafari E; Danaei G
    Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J; Egli M
    Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular pharmacotherapy in old age: How beneficial is it? What does it cost?].
    Gysling E
    Praxis (Bern 1994); 1995 Oct; 84(44):1248-51. PubMed ID: 7491446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
    Joshi SR
    J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
    [No Abstract]   [Full Text] [Related]  

  • 11. [A woman with anginal symptoms and normal coronary arteries].
    Asselman MA; Westra SW; Verheugt FW
    Ned Tijdschr Geneeskd; 2008 Oct; 152(40):2155-9. PubMed ID: 18953775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.
    Green LW
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S4-8; discussion S9. PubMed ID: 16052194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beneficial effects of statins and angiotensin converting enzyme inhibitors on aggregability of red blood cells in hypertensive patients].
    Korbut RA; Guzik B; Adamek-Guzik T; Korbut R
    Folia Med Cracov; 2006; 47(1-4):37-49. PubMed ID: 18038611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. News of the polypill.
    Marshall T
    BMJ; 2008 Oct; 337():a2160. PubMed ID: 18936068
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary prevention of coronary artery disease in urban Indian primary care.
    Gupta R
    Int J Cardiol; 2009 Jun; 135(2):184-6. PubMed ID: 18620762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
    Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stable angina pectoris can be treated successfully by drugs alone--pro].
    Schneider CA; Erdmann E
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2024. PubMed ID: 17882742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.